Principal Investigator
Maria Carpintero
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20240069
Clinical Trial Summary
SELECT-SLE: A Phase 3 Program to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Moderately to Severely Active SLE
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Niurka Colina
Phone Number
+1 (305) 2436405
Email
nxc610@miami.edu